US Only Archives - European Medical Journal

Pulmonologists' Pocket Guide to Non-Small Cell Lung Cancer Care

From the first suspicion of lung cancer through diagnosis, treatment, and long-term management, pulmonologists remain central to the…

Paradigm Shift in ESR1 Testing: Spot Resistance Earlier

Explore ESR1 mutations in HR-positive breast cancer and how early ctDNA monitoring may help delay endocrine resistance…

Zongertinib: A New Option In HER2-Mutant NSCLC

HER2 (ERBB2)-mutant metastatic non-small cell lung cancer (NSCLC) remains a clinical challenge, with limited treatment options and…

11 Sep 2025

An FDA approval for certain patients with endometrial cancer

Interview: Tina Tan

My mission and vision for IDSA during my tenure as President have been to continue advocating strongly for the society’s strategic…

The Role of IL-5 in Inflammatory Diseases

This infographic explores the expanding understanding of interleukin-5 (IL-5) in inflammatory diseases, highlighting that IL-5 impacts…

24 Jun 2025

Explore the Mechanism of Action and 5-Year Data of Deucravacitinib

Learn about the mechanism of action and latest clinical safety and efficacy data of deucravacitinib.

Emerging Strategies for Stage II Seminoma Seek to Minimize Harm Without Sacrificing Cure

Efforts to optimize treatment for Stage II testicular seminoma are intensifying, as new approaches aim to reduce long-term toxicity while preserving the high cure rates associated with standard therapies.

Adjuvant Nivolumab in MIBC: Lessons from CheckMate 274

New analysis reveals nivolumab’s impact on disease-free survival in high-risk muscle-invasive bladder cancer.

AMJ Oncology 2 [Supplement 2] 2025

New findings from an extended analysis of the CheckMate 274 trial offer fresh insight into post-surgical treatment for high-risk…